drugset / Trial / NCT01257074

Non-inferiority Comparison of Efficacy and Safety of Penciclovir 10mg/g to Acyclovir 50mg/g in the Treatment of Recurrent Herpes Labialis

NCT01257074

Phase 3 Completed 76 enrolled EMS
RandomizedParallel-groupTriple-blindTreatment

Summary

Herpes labialis is the most common recurrent manifestation of herpes simplex. The purpose of this study is to check the non-inferiority efficacy and safety of penciclovir 10mg/g as treatment for Herpes Labialis in comparison to acyclovir 50mg/g.

Timeline

Start
2012-02
Primary completion
2012-03
Completion
2012-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Acyclovir Small molecule 50 unknown Topical
Subject Penciclovir Small molecule 10 unknown Topical

Indications